Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gilbert

Showing results (651-660 of 869) with videos related to

Pageof 87
Sort By:
The Journal of Infectious Diseases|August 19, 2005
HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1-infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccinePeter B Gilbert, Marta L Ackers, Phillip W Berman, et al.
Anais Da Academia Brasileira De Ciencias|July 21, 1999
Activities of the Pharmaceutical Technology Institute of the Oswaldo Cruz Foundation with medicinal, insecticidal and insect repellent plantsB Gilbert, D F Teixeira, E S Carvalho, et al.
The Journal of Infectious Diseases|December 2, 2017
Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin AmericaZoe Moodie, Michal Juraska, Ying Huang, et al.
Ophthalmology|April 27, 2025
Neurotrophic Keratopathy in Pediatric Population: An IRIS® Registry ReportAsmaa A Zidan, Joshua B Gilbert, Eric Goldberg, et al.
BMC Research Notes|February 9, 2013
Purification of native HBHA from Mycobacterium avium subsp. paratuberculosisLouise H Lefrancois, Christelle C Bodier, Sophie Lecher, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 15, 2022
Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials dataDani Cohen, Shai Ashkenazi, Rachel Schneerson, et al.
Plos One|December 14, 2018
Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic diseaseChloé Pasin, M Elizabeth Halloran, Peter B Gilbert, et al.
Ophthalmology. Retina|March 26, 2026
Timing and Determinants of Post-Injection Endophthalmitis After First-Time Anti-VEGF Administration: A Retrospective National Study in the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)Sophia Y Ghauri, Connor Ross, Joshua B Gilbert, et al.
Open Forum Infectious Diseases|January 19, 2023
Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy TrialYouyi Fong, Ying Huang, Bhavesh Borate, et al.
Ophthalmology. Retina|September 11, 2024
Intravitreal Antibiotics versus Early Vitrectomy Plus Intravitreal Antibiotics for Postinjection Endophthalmitis: An IRIS® (Intelligent Research in Sight Registry) AnalysisConnor J Ross, Sophia Ghauri, Joshua B Gilbert, et al.
Pageof 87

Showing results (651-660 of 869) with videos related to

Sort By:
Pageof 87
The Journal of Infectious Diseases|August 19, 2005
HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1-infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccinePeter B Gilbert, Marta L Ackers, Phillip W Berman, et al.
Anais Da Academia Brasileira De Ciencias|July 21, 1999
Activities of the Pharmaceutical Technology Institute of the Oswaldo Cruz Foundation with medicinal, insecticidal and insect repellent plantsB Gilbert, D F Teixeira, E S Carvalho, et al.
The Journal of Infectious Diseases|December 2, 2017
Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin AmericaZoe Moodie, Michal Juraska, Ying Huang, et al.
Ophthalmology|April 27, 2025
Neurotrophic Keratopathy in Pediatric Population: An IRIS® Registry ReportAsmaa A Zidan, Joshua B Gilbert, Eric Goldberg, et al.
BMC Research Notes|February 9, 2013
Purification of native HBHA from Mycobacterium avium subsp. paratuberculosisLouise H Lefrancois, Christelle C Bodier, Sophie Lecher, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 15, 2022
Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials dataDani Cohen, Shai Ashkenazi, Rachel Schneerson, et al.
Plos One|December 14, 2018
Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic diseaseChloé Pasin, M Elizabeth Halloran, Peter B Gilbert, et al.
Ophthalmology. Retina|March 26, 2026
Timing and Determinants of Post-Injection Endophthalmitis After First-Time Anti-VEGF Administration: A Retrospective National Study in the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)Sophia Y Ghauri, Connor Ross, Joshua B Gilbert, et al.
Open Forum Infectious Diseases|January 19, 2023
Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy TrialYouyi Fong, Ying Huang, Bhavesh Borate, et al.
Ophthalmology. Retina|September 11, 2024
Intravitreal Antibiotics versus Early Vitrectomy Plus Intravitreal Antibiotics for Postinjection Endophthalmitis: An IRIS® (Intelligent Research in Sight Registry) AnalysisConnor J Ross, Sophia Ghauri, Joshua B Gilbert, et al.
Pageof 87